AI C. C. T. A. Guides Optimal L. L. M. Benefit 04/06/26 episode artwork

EPISODE · Apr 7, 2026

AI C. C. T. A. Guides Optimal L. L. M. Benefit 04/06/26

from Cardiology Today · host Deconstructed Cardiology

Welcome to Cardiology Today – Recorded April 06, 2026. This episode summarizes 5 key cardiology studies on topics like rehabilitation needs and coronary computed tomography angiography. Key takeaway: AI C. C. T. A. Guides Optimal L. L. M. Benefit. Article Links: Article 1: Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. (ESC heart failure) Article 2: Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. (ESC heart failure) Article 3: Quantitative Coronary Atherosclerotic Plaque Burden From CCTA and the Benefit From Lipid-Lowering Medication. (Circulation. Cardiovascular imaging) Article 4: The inferior vena cava collapsibility index as a non-invasive marker of early haemodynamic changes following atrial septal defect closure. (Cardiology in the young) Article 5: Physical therapy enhances patient care in post-congenital heart surgery clinic. (Cardiology in the young) Full episode page: https://podcast.explainheart.com/podcast/ai-c-c-t-a-guides-optimal-l-l-m-benefit-04-06-26/ Featured Articles Article 1: Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41941602 Summary: This post hoc analysis from the cardiac microcurrent (C-MIC) two trial highlighted that the precise relationship between changes in cardiac function, functional capacity, and patient-reported health status in chronic Heart Failure remains incompletely defined. The C-MIC two trial evaluated the efficacy and safety of cardiac microcurrent therapy in patients with chronic Heart Failure with Reduced Ejection Fraction receiving optimal guideline-directed medical therapy. This study confirmed the ongoing need for research into how distinct clinical domains reflect treatment response for this patient population. Article 2: Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41941602 Summary: This post hoc analysis from the cardiac microcurrent (C-MIC) two trial highlighted that the precise relationship between changes in cardiac function, functional capacity, and patient-reported health status in chronic Heart Failure remains incompletely defined. The C-MIC two trial evaluated the efficacy and safety of cardiac microcurrent therapy in patients with chronic Heart Failure with Reduced Ejection Fraction receiving optimal guideline-directed medical therapy. This study confirmed the ongoing need for research into how distinct clinical domains reflect treatment response for this patient population. Article 3: Quantitative Coronary Atherosclerotic Plaque Burden From CCTA and the Benefit From Lipid-Lowering Medication. Journal: Circulation. Cardiovascular imaging PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41937634 Summary: This observational cohort study found that artificial intelligence-guided quantitative coronary computed tomography angiography identified patients who derive outcome benefit from lipid-lowering medication. The study showed that quantification of coronary atherosclerotic plaque burden, specifically percent atheroma volume, serves as a marker for guiding therapy. This demonstrates that advanced imaging can personalize lipid-lowering medication strategies for symptomatic patients with suspected coronary artery disease. Article 4: The inferior vena cava collapsibility index as a non-invasive marker of early haemodynamic changes following atrial septal defect closure. Journal: Cardiology in the young PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41940521 Summary: This retrospective study found that the inferior vena cava collapsibility index serves as a non-invasive marker for early hemodynamic changes following transcatheter closure of an atrial septal defect. The study assessed changes in pulmonary artery, pulmonary vein, and inferior vena cava flow parameters in 31 pediatric patients. This demonstrates a valuable tool for monitoring immediate post-procedural cardiovascular adjustments in young patients with hemodynamically significant atrial septal defects, defined as Qp over Qs greater than or equal to 1.5. Article 5: Physical therapy enhances patient care in post-congenital heart surgery clinic. Journal: Cardiology in the young PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41940519 Summary: This retrospective review found that routine physical therapy evaluation significantly enhances patient care in post-congenital heart surgery clinics. The study assessed posture, mobility, and pain in patients following congenital heart surgery requiring sternotomy. This demonstrated that physical therapy effectively identifies rehabilitation needs and addresses gaps in care, improving post-operative management for these patients. Transcript Today’s date is April 06, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. This post hoc analysis from the cardiac microcurrent (C-MIC) two trial highlighted that the precise relationship between changes in cardiac function, functional capacity, and patient-reported health status in chronic Heart Failure remains incompletely defined. The C-MIC two trial evaluated the efficacy and safety of cardiac microcurrent therapy in patients with chronic Heart Failure with Reduced Ejection Fraction receiving optimal guideline-directed medical therapy. This study confirmed the ongoing need for research into how distinct clinical domains reflect treatment response for this patient population. Article number two. Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. This post hoc analysis from the cardiac microcurrent (C-MIC) two trial highlighted that the precise relationship between changes in cardiac function, functional capacity, and patient-reported health status in chronic Heart Failure remains incompletely defined. The C-MIC two trial evaluated the efficacy and safety of cardiac microcurrent therapy in patients with chronic Heart Failure with Reduced Ejection Fraction receiving optimal guideline-directed medical therapy. This study confirmed the ongoing need for research into how distinct clinical domains reflect treatment response for this patient population. Article number three. Quantitative Coronary Atherosclerotic Plaque Burden From CCTA and the Benefit From Lipid-Lowering Medication. This observational cohort study found that artificial intelligence-guided quantitative coronary computed tomography angiography identified patients who derive outcome benefit from lipid-lowering medication. The study showed that quantification of coronary atherosclerotic plaque burden, specifically percent atheroma volume, serves as a marker for guiding therapy. This demonstrates that advanced imaging can personalize lipid-lowering medication strategies for symptomatic patients with suspected coronary artery disease. Article number four. The inferior vena cava collapsibility index as a non-invasive marker of early haemodynamic changes following atrial septal defect closure. This retrospective study found that the inferior vena cava collapsibility index serves as a non-invasive marker for early hemodynamic changes following transcatheter closure of an atrial septal defect. The study assessed changes in pulmonary artery, pulmonary vein, and inferior vena cava flow parameters in 31 pediatric patients. This demonstrates a valuable tool for monitoring immediate post-procedural cardiovascular adjustments in young patients with hemodynamically significant atrial septal defects, defined as Qp over Qs greater than or equal to 1.5. Article number five. Physical therapy enhances patient care in post-congenital heart surgery clinic. This retrospective review found that routine physical therapy evaluation significantly enhances patient care in post-congenital heart surgery clinics. The study assessed posture, mobility, and pain in patients following congenital heart surgery requiring sternotomy. This demonstrated that physical therapy effectively identifies rehabilitation needs and addresses gaps in care, improving post-operative management for these patients. Thank you for listening. Don’t forget to subscribe. Keywords rehabilitation needs, coronary computed tomography angiography, functional capacity, post-operative care, Heart Failure, patient-reported health status, atherosclerotic plaque burden, ejection fraction, artificial intelligence, physical therapy, inferior vena cava collapsibility index, lipid-lowering medication, congenital heart surgery, pediatric cardiology, hemodynamic changes, percent atheroma volume, atrial septal defect, transcatheter closure, cardiac microcurrent therapy. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post AI C. C. T. A. Guides Optimal L. L. M. Benefit 04/06/26 first appeared on Cardiology Today.

Episode metadata supplied by the publisher feed · Published Apr 7, 2026

Embed this episode

Welcome to Cardiology Today – Recorded April 06, 2026. This episode summarizes 5 key cardiology studies on topics like rehabilitation needs and coronary computed tomography angiography. Key takeaway: AI C. C. T. A. Guides Optimal L. L. M. Benefit. Article Links: Article 1: Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. (ESC heart failure) Article 2: Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. (ESC heart failure) Article 3: Quantitative Coronary Atherosclerotic Plaque Burden From CCTA and the Benefit From Lipid-Lowering Medication. (Circulation. Cardiovascular imaging) Article 4: The inferior vena cava collapsibility index as a non-invasive marker of early haemodynamic changes following atrial septal defect closure. (Cardiology in the young) Article 5: Physical therapy enhances patient care in post-congenital heart surgery clinic. (Cardiology in the young) Full episode page: https://podcast.explainheart.com/podcast/ai-c-c-t-a-guides-optimal-l-l-m-benefit-04-06-26/ Featured Articles Article 1: Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41941602 Summary: This post hoc analysis from the cardiac microcurrent (C-MIC) two trial highlighted that the precise relationship between changes in cardiac function, functional capacity, and patient-reported health status in chronic Heart Failure remains incompletely defined. The C-MIC two trial evaluated the efficacy and safety of cardiac microcurrent therapy in patients with chronic Heart Failure with Reduced Ejection Fraction receiving optimal guideline-directed medical therapy. This study confirmed the ongoing need for research into how distinct clinical domains reflect treatment response for this patient population. Article 2: Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II Trial. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41941602 Summary: This post hoc analysis from the cardiac microcurrent (C-MIC) two trial highlighted that the precise relationship between changes in cardiac function, functional capacity, and patient-reported health status in chronic Heart Failure remains incompletely defined. The C-MIC two trial evaluated the efficacy and safety of cardiac microcurrent therapy in patients with chronic Heart Failure with Reduced Ejection Fraction receiving optimal guideline-directed medical therapy. This study confirmed the ongoing need for research into how distinct clinical domains reflect treatment response for this patient population. Article 3: Quantitative Coronary Atherosclerotic Plaque Burden From CCTA and the Benefit From Lipid-Lowering Medication. Journal: Circulation. Cardiovascular imaging PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41937634 Summary: This observational cohort study found that artificial intelligence-guided quantitative coronary computed tomography angiography identified patients who derive outcome benefit from lipid-lowering medication. The study showed that quantification of coronary atherosclerotic plaque burden, specifically percent atheroma volume, serves as a marker for guiding therapy. This demonstrates that advanced imaging can personalize lipid-lowering medication strategies for symptomatic patients with suspected coronary artery disease. Article 4: The inferior vena cava collapsibility index as a non-invasive marker of early haemodynamic changes following atrial septal defect closure. Journal: Cardiology in the young PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41940521 Summary: This retrospective study found that the inferior vena cava collapsibility index serves as a non-invasive marker for early hemodynamic changes following transcatheter closure of an atrial sept

Distinct summary based on available episode metadata or transcript content.

Ready to play

AI C. C. T. A. Guides Optimal L. L. M. Benefit 04/06/26

0:00 0:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

When was this Cardiology Today episode published?

This episode was published on April 7, 2026.

Can I download this Cardiology Today episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!